Microfluidics for 3D Cell and Tissue Cultures: Microfabricative and Ethical Aspects Updates

Area of Science:

• Biomedical Engineering
• Cell Biology
• Drug Discovery

Background:

• Conventional 2D cell screening assays have limitations in mimicking in vivo tissue morphology and physiology.
• There is a critical need for improved in vitro models in pharmaceutical research, preclinical screening, and clinical diagnostics.
• Current methods often show limited correlation between in vitro and in vivo data, necessitating better experimental approaches.

Purpose of the Study:

• To review the limitations of conventional cell culture and screening procedures.
• To highlight the importance of mimicking the in vivo microenvironment in cell-based assays.
• To introduce microfluidic devices as a solution to enhance the accuracy and efficiency of in vitro screening.

Main Methods:

• Discussion of the physical aspects of the in vivo micro and nano environment.
• Analysis of the shortcomings of traditional two-dimensional (2D) cell culture.
• Introduction and description of microfluidic tools and their components.

Main Results:

• Identified limitations in current in vitro cell screening assays, including poor mimicry of native tissue.
• Highlighted the challenges and ethical considerations associated with animal testing.
• Presented microfluidic devices as a promising technology to address these issues.

Conclusions:

• Microfluidic devices offer a viable alternative to conventional cell screening methods.
• These advanced systems can better replicate in vivo conditions, leading to more reliable data.
• The adoption of microfluidics supports the 3Rs ethical principles by reducing reliance on animal models.